Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 420Lymphoma, Large B-Cell, Diffuse 93Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Follicular 79Recurrence 68Lymphoma 60Neoplasms, Plasma Cell 57Lymphoma, Mantle-Cell 56Lymphoma, B-Cell, Marginal Zone 47Lymphoma, Non-Hodgkin 46Leukemia, Myeloid, Acute 34Leukemia 32Lymphoma, B-Cell 24Neoplasms 23Myelodysplastic Syndromes 23Waldenstrom Macroglobulinemia 18Hodgkin Disease 18Smoldering Multiple Myeloma 17Lymphoma, T-Cell, Peripheral 16Burkitt Lymphoma 14Hematologic Diseases 13Lymphoma, T-Cell, Cutaneous 12Lymphoma, T-Cell 12Prostatic Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Sezary Syndrome 10Mycosis Fungoides 10Lymphoma, Large-Cell, Anaplastic 9Leukemia, Myelomonocytic, Chronic 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Lenalidomide × Clear all
NCT00684242 2013-01-28

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts

Cancer Pain, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡